William Decker Lab

Decker Lab Publications


Konduri, Vanaja, et al. “A Subset of Cytotoxic Effector Memory T Cells Enhances CAR T Cell Efficacy in a Model of Pancreatic Ductal Adenocarcinoma.” Science Translational Medicine, vol. 13, no. 592, 5 May 2021, doi:10.1126/scitranslmed.abc3196.

Konduri, Vanaja, et al. “CD8 CD161 T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential.” Frontiers in Immunology, vol. 11, 1 Feb. 2021, p. 3621., doi:10.3389/fimmu.2020.613204.

Oyewole-Said, Damilola, et al. “Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.” Frontiers in Immunology, vol. 11, 15 Dec. 2020, p. 3168., doi:10.3389/fimmu.2020.608024.

Verrico, Chris D., et al. “A Randomized, Double-Blind, Placebo-Controlled Study of Daily Cannabidiol for the Treatment of Canine Osteoarthritis Pain.” Pain, vol. 161, no. 9, 1 Sept. 2020, pp. 2191–2202., doi:10.1097/j.pain.0000000000001896.

Halpert, Matthew M., et al. “MHC Class I and II Peptide Homology Regulates the Cellular Immune Response.” The FASEB Journal, vol. 34, no. 6, June 2020, pp. 8082–8101., doi:10.1096/fj.201903002r.

Konduri, V., et al. “Dendritic Cell Vaccination plus Low-Dose Doxorubicin for the Treatment of Spontaneous Canine Hemangiosarcoma.” Cancer Gene Therapy, vol. 26, no. 9, 2019, pp. 282–291., doi:10.1038/s41417-019-0080-3.

Decker, William K., et al. “Immunotherapy for Invasive Mold Disease in Transplant Patients: Dendritic Cell Immunotherapy, Interferon Gamma, Recombinant Myeloid Growth Factors, and Healthy Donor Granulocyte Transfusions.” Principles and Practice of Transplant Infectious Diseases, 14 June 2019, pp. 1031–1040., doi:10.1007/978-1-4939-9034-4_58.

Halpert, Matthew, et al. “Regulation and In Vivo Function of Dendritic Cell CTLA-4.” The Journal of Immunology, vol. 200, no. 1, 1 May 2018, p. 109.11.

Liang, Dan, et al. “AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity.” Frontiers in Immunology, vol. 8, 15 Jan. 2018, p. 1801., doi:10.3389/fimmu.2017.01801.

Konduri, Vanaja, et al. “Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy.” Infection and Immunity, vol. 85, no. 9, 18 Aug. 2017, pp. e00127–17., doi:10.1128/iai.00127-17.

Decker, William K., et al. “Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models.” Frontiers in Immunology, vol. 8, 2 Aug. 2017, p. 829., doi:10.3389/fimmu.2017.00829.

Decker, William Karl, et al. “Active Specific Immunotherapy for Lethal Canine Hemangiosarcoma: A Model System for the Treatment of Angiosarcoma with Curative Intent.” Journal of Clinical Oncology, vol. 35, no. 15_suppl, 20 May 2017, pp. e14539–e14539., doi:10.1200/jco.2017.35.15_suppl.e14539.

Konduri, Vanaja, et al. “ Active Specific Immunotherapy plus Doxorubicin Chemotherapy Mediates Durable Remission of Lethal Canine Hemangiosarcoma.” The Journal of Immunology, vol. 198, no. 1-supplement, 1 May 2017, p. 198.3.

Konduri, Vanaja, et al. “Chemo-Immunotherapy Mediates Durable Cure of Orthotopic KrasG12D/p53−/−Pancreatic Ductal Adenocarcinoma.” OncoImmunology, vol. 5, no. 9, 1 Sept. 2016, p. e1213933., doi:10.1080/2162402x.2016.1213933.

Halpert, Matthew M., et al. “Dendritic Cell-Secreted Cytotoxic T-Lymphocyte-Associated Protein-4 Regulates the T-Cell Response by Downmodulating Bystander Surface B7.” Stem Cells and Development, vol. 25, no. 10, 15 May 2016, pp. 774–787., doi:10.1089/scd.2016.0009.

Konduri, Vanaja, et al. “ Low Dose Gemcitabine plus TH1 Dendritic Cell Vaccination Mediates Durable Cure of Orthotopic KrasG12D/p53−/− Pancreatic Ductal Adenocarcinoma via the Generation of Atypical ….” The Journal of Immunology, vol. 196, no. 1-supplement, 1 May 2016, p. 75.23.

Liang, D., et al. “Stepping Out of the Cytosol: AIMp1/p43 Potentiates the Link Between Innate and Adaptive Immunity.” International Reviews of Immunology, vol. 34, no. 5, 3 Sept. 2015, pp. 367–381., doi:10.3109/08830185.2015.1077829.

Halpert, Matthew, et al. “Mature Dendritic Cells Secrete Functionally Active CTLA-4 in Microvesicles.” The Journal of Immunology, vol. 194, no. 1-supplement, 1 May 2015, p. 128.11.

Liang, Dan, et al. “ Multi-Enzyme Aminoacyl TRNA Synthetase Complex Component AIMp1/p43 as an Important Th1 Mediator (IRC7P. 428).” The Journal of Immunology, vol. 194, no. 1-supplement, 1 May 2015, p. 128.9.

Halpert, Matthew, et al. “ Dendritic Cell Homologous Antigenic Loading Initiates AIMp1-Mediated TH1 Immunity (IRC7P. 432).” The Journal of Immunology, vol. 194, no. 1-supplement, 1 May 2015, p. 128.13.

Konduri, Vanaja, et al. “ Therapeutic Platform for Immunotherapy of Chagas Disease (VAC9P. 1106).” The Journal of Immunology, vol. 194, no. 1-supplement, 1 May 2015, p. 145.14.

Konduri, Vanaja, et al. “Modeling Dendritic Cell Vaccination for Influenza Prophylaxis: Potential Applications for Niche Populations.” The Journal of Infectious Diseases, vol. 207, no. 11, 1 June 2013, pp. 1764–1772., doi:10.1093/infdis/jit087.

Halpert, Matthew, et al. “Immunosurgical Resection of Host Tissues Mediated by a Novel Dendritic Cell-Based Vaccine Proficient in the Promulgation of TH1 Immunity by Exploitation of the p43/SCTLA-4 Axis (P4248).” The Journal of Immunology, vol. 190, no. 1-supplement, 1 May 2013, p. 47.12.

Collins-Pautz, Matthew, et al. “ Delivery of a Genetic Cancer Vaccine Containing a Small Molecule Inducible Immune Adjuvant by in Vivo Electroporation (EVac)(P4332).” The Journal of Immunology, vol. 190, no. 1-supplement, 1 May 2013, p. 45.14.

Kumar RD, Burns BA, Vandeventer PJ, Luna PN, Shaw CA. Selection for or against escape from nonsense mediated decay is a novel signature for the detection of cancer genes. Cancer Genet. 2021 Nov;258-259:80-84. doi: 10.1016/j.cancergen.2021.09.003. Epub 2021 Sep 23. PMID: 34592632.